Carpenter Technology Corporation
284.66USD
-7.6000 (-2.60%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on CRS.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.94▲ | $2.86 | 1 | 0 |
| Next quarter | $3.49▲ | $3.4 | 1 | 0 |
| Current year | $13.44▲ | $12.91 | 2 | 0 |
| Next year | $15.97▲ | $15.36 | 2 | 0 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-09-30 | $3.03 | $3.25 | +0.22 (+7.2%) |
| 2026-06-30 | $3.08 | $3.23 | +0.15 (+4.7%) |
| 2026-03-31 | $2.64 | $2.77 | +0.13 (+4.8%) |
| 2025-12-31 | $2.22 | $2.33 | +0.11 (+4.9%) |
88 ratings from 20 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| BTIG | Maintained | Buy | $620 $470 | Oct 23, 2026 |
| JP Morgan | Maintained | Overweight | $700 $520 | Oct 14, 2026 |
| TD Cowen | Maintained | Buy | $650 $500 | Oct 9, 2026 |
| Keybanc | Maintained | Overweight | $608 $465 | Oct 8, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $540 $430 | Sep 30, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $425 $540 | Aug 4, 2026 |
| Keybanc | Maintained | Overweight | $644 $608 | Aug 3, 2026 |
| JP Morgan | Maintained | Overweight | $705 $700 | Jul 31, 2026 |
| Susquehanna | Maintained | Positive | $680 $600 | Jul 31, 2026 |
| BTIG | Maintained | Buy | $450 $620 | Jul 31, 2026 |
| JP Morgan | Maintained | Overweight | $470 $705 | Jul 14, 2026 |
| TD Cowen | Maintained | Buy | $470 $650 | Jul 13, 2026 |
| Susquehanna | Maintained | Positive | $495 $680 | Jul 9, 2026 |
| Keybanc | Maintained | Overweight | $459 $644 | Jun 30, 2026 |
| TD Cowen | Maintained | Buy | $450 $470 | May 22, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $400 $425 | May 4, 2026 |
| Keybanc | Maintained | Overweight | $453 $459 | May 4, 2026 |
| JP Morgan | Maintained | Overweight | $465 $470 | Apr 30, 2026 |
| TD Cowen | Maintained | Buy | $430 $450 | Apr 30, 2026 |
| Susquehanna | Maintained | Positive | $470 $495 | Apr 30, 2026 |
| BTIG | Maintained | Buy | $375 $450 | Apr 30, 2026 |
| JP Morgan | Maintained | Overweight | $394 $465 | Apr 20, 2026 |
| Keybanc | Maintained | Overweight | $380 $453 | Apr 9, 2026 |
| Wells Fargo | Initiated | Equal-Weight | $400 | Apr 1, 2026 |
| Susquehanna | Initiated | Positive | $470 | Mar 3, 2026 |
100 filings from 20 insiders · 16 buy / 7 sell over 6m
Officers and directors of CRS, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| WARD JR STEPHEN MDirector | ExerciseDirector Stock Option (Right to Buy) | 3.3k | — | — | Oct 9, 2026 |
| WARD JR STEPHEN MDirector | Tax | 338 | $385.81 | $130k | Oct 9, 2026 |
| WARD JR STEPHEN MDirector | Exercise | 3.3k | $39.79 | $130k | Oct 9, 2026 |
| MCLANE CHARLES DOUGLAS JRDirector | GrantDirector Stock Option (Right to Buy) | 193 | — | — | Oct 6, 2026 |
| MCLANE CHARLES DOUGLAS JRDirector | GrantDirector Stock Units | 361 | — | — | Oct 6, 2026 |
| HART ANASTASIOS JOHNDirector | GrantDirector Stock Option (Right to Buy) | 193 | — | — | Oct 6, 2026 |
| HART ANASTASIOS JOHNDirector | GrantDirector Stock Units | 361 | — | — | Oct 6, 2026 |
| ACOFF VIOLA LDirector | GrantDirector Stock Option (Right to Buy) | 193 | — | — | Oct 6, 2026 |
| ACOFF VIOLA LDirector | GrantDirector Stock Units | 361 | — | — | Oct 6, 2026 |
| Younessi RaminDirector | GrantDirector Stock Option (Right to Buy) | 193 | — | — | Oct 6, 2026 |
| Younessi RaminDirector | GrantDirector Stock Units | 361 | — | — | Oct 6, 2026 |
| Giacobbe KenDirector | GrantDirector Stock Option (Right to Buy) | 193 | — | — | Oct 6, 2026 |
| Giacobbe KenDirector | GrantDirector Stock Units | 361 | — | — | Oct 6, 2026 |
| BECK JULIE ADirector | GrantDirector Stock Option (Right to Buy) | 193 | — | — | Oct 6, 2026 |
| BECK JULIE ADirector | GrantDirector Stock Units | 361 | — | — | Oct 6, 2026 |
| LIGOCKI KATHLEENDirector | GrantDirector Stock Option (Right to Buy) | 193 | — | — | Oct 6, 2026 |
| LIGOCKI KATHLEENDirector | GrantDirector Stock Units | 361 | — | — | Oct 6, 2026 |
| KAROL STEVEN EDirector | GrantDirector Stock Option (Right to Buy) | 193 | — | — | Oct 6, 2026 |
| KAROL STEVEN EDirector | GrantDirector Stock Units | 361 | — | — | Oct 6, 2026 |
| WARD JR STEPHEN MDirector | GrantDirector Stock Option (Right to Buy) | 193 | — | — | Oct 6, 2026 |
No analyst notes on CRS yet.
Analyst Ratings
8 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 6 | 1 | 0 | 0 | Buy2.00 |
| 1 mo ago | 1 | 6 | 1 | 0 | 0 | Buy2.00 |
| 2 mo ago | 1 | 6 | 1 | 0 | 0 | Buy2.00 |
| 3 mo ago | 1 | 7 | 1 | 0 | 0 | Buy2.00 |
Members whose judged calls on CRS have played out most reliably.
No settled calls on CRS yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice